News

Israeli medical developer raises US$9m to help women with pelvic organ prolapse

By Published On: October 21, 2022
Israeli medical developer raises US$9m to help women with pelvic organ prolapse

An Israeli medical developer has raised US$9m series B financing to advance its prolapse repair technology. 

FEMSelect has developed EnPlace, a less invasive, meshless approach to prolapse repair, to help women diagnosed with pelvic organ prolapse – a medical condition that occurs when one or more of the organs in the pelvis slip down from their normal position and bulge into the vagina.

The current standard of care includes hysterectomy or complex mesh surgery which some women want to avoid.

The company says its technology enables a minimally invasive approach in under 30 minutes and according to clinical studies, women can return to normal activities within a few days.

EnPlace system’s approach is cleared by the FDA for pelvic floor ligament fixation for the management of symptomatic uterine prolapse, a complication in the lives of nearly 50 per cent of women over the age of 50.

The investment round, led by New Age Ventures and co-led by TriVentures, will support the growth and market penetration of EnPlace, primarily in the US.

The financing comes after the system’s recent launches in the US and Israel and supported by clinical data on EnPlace’s apical repair success rate of 92.3 per cent at four years, as reported in the peer review International Journal of Gynecology and Obstetrics.

In the past year, FEMSelect has partnered with women’s healthcare company LiNA Medical USA, educating physicians on the technology, currently available in more than 25 states across the US

Earlier this year, EnPlace has obtained a procedure code from the Centers for Medicare and Medicaid Services (CMS) enabling healthcare facilities to receive reimbursement for the procedure.

Debbie Garner, co-CEO of FEMSelect, said: “This investment is a testament to our team and the EnPlace system.

“It enables us to expand the medical and patient communities and to serve many more women who are seeking a minimally invasive treatment option. This is a tremendous step forward for the company.”

 

US virtual abortion clinic raises US$6.1m to expand abortion access post Roe v Wade
Telehealth abortion service expands across the US to allow people to have safe abortions at home